Poseida Therapeutics Inc. (PSTX)
NASDAQ: PSTX
· Real-Time Price · USD
9.50
0.00 (0.00%)
At close: Jan 07, 2025, 10:00 PM
Poseida Therapeutics Revenue
Poseida Therapeutics reported an annual revenue of $64.7M, reflecting a -50.37% growth. For the quarter ending September 30, 2024, Poseida Therapeutics generated $71.75M in revenue.
Revenue (ttm)
64.7M
Revenue Growth
-50.37%
Price / Sales Ratio
4.68
Revenue / Employee
184.87K
Employees
350
Market Cap
925.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 64.7M | -50.37% |
| Dec 31, 2022 | 130.36M | +417217.08% |
| Dec 31, 2021 | 31.24K | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | -100.00% |
| Dec 31, 2017 | 2.98M | -69.44% |
| Dec 31, 2016 | 9.77M | n/a |